I've been wanting to add CRMD, since their product obviously works, but knowing that there is an FDA meeting almost 5 months away, CRMD needs cash, and Khoso is still CEO, I will hold off until at least Jan. 1st. There may be a drift upwards before the FDA meeting then. Also have to factor in that people may sell CRMD for a loss in December and then reacquire.
I think BSGM moves upwards more from now until the end of December, especially at these silly prices, knowing machines are being installed. Haven't heard of any place where they are at having them get removed due to lack of performance or fear of the software model. Visibility will continue to increase, and demand along with it, imo. So I'll continue to take advantage of these prices to add more via my 401K in 4Q2020. Hard to believe BSGM was at $2.56 in March. (Back when short trolls and other failures were bashing it.)
Here's to both companies products being available for patients in meaningful numbers in 2021.